AKBM SRL
The score of AKBM shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -51 % Total assets -28 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AKBM's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 69,955 € | ||||
| Equity | 125,501 € | ||||
| Cash | 87,961 € | ||||
| EBITDA | 168,022 € | ||||
| Total assets | 697,186 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 15 Dec 2025
- Year ended 30 Jun 2024filed on 17 Dec 2024
- Year ended 30 Jun 2023filed on 09 Jan 2024
- Year ended 30 Jun 2022filed on 30 Jan 2023
- Year ended 30 Jun 2021filed on 17 Jan 2022
AKBM's financial analysis
- Solvency18.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AKBM
AKBM's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0683.802.092
- VAT number
- BE0683802092
- Peppol
- Registered · 0208:0683802092 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Oct 2017
- Registered office
- 8870 Izegem
- Latest accounts
- 2025 · filed on 15 Dec 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
AKBM (SRL) has been based in Izegem since 2017, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 69,955 € and equity of 125,501 €; its revenue is not published. Its solvency stands at 18.0%, below the median of its sector (44.2%).
Companies similar to AKBM
Companies in the same business, of comparable size and area, outside its group.
- MT Pharma Retail sale of pharmaceutical products Léglise · balance sheet 697,338 €
- Aubelpharma Retail sale of pharmaceutical products Aubel · balance sheet 696,844 €
- Apotheek Opwijk Lenaerts Retail sale of pharmaceutical products Opwijk · balance sheet 697,583 €
- Pharmacie Anne Scauflaire Retail sale of pharmaceutical products Charleroi · balance sheet 697,631 €
- 3-Folia Retail sale of pharmaceutical products Ghent · balance sheet 696,291 €
- Pharmacare Retail sale of pharmaceutical products Herent · balance sheet 695,856 €
- Phaladel Retail sale of pharmaceutical products Braine-le-Comte · balance sheet 694,145 €
- Masy Pharma Retail sale of pharmaceutical products Vilvoorde · balance sheet 700,251 €
Frequently asked questions about AKBM
What is the revenue of AKBM?
AKBM files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AKBM?
In Belgium, the VAT number is the company number prefixed with BE: BE0683802092 for AKBM, if the company is VAT-registered. Its company number (CBE) is 0683.802.092.
Where is the registered office of AKBM?
According to the CBE register, the registered office of AKBM is in 8870 Izegem.
What is the equity of AKBM?
At the close of the 2025 financial year, the equity of AKBM amounts to 125,501 €, a solvency of 18.0% of total assets.
Who manages AKBM?
The register lists 2 active mandates at AKBM. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AKBM
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →